| scholarly article | Q13442814 |
| P50 | author | Yuki Kondo | Q59705484 |
| Yoichi Ishitsuka | Q73209250 | ||
| P2093 | author name string | Tetsumi Irie | |
| Takumi Era | |||
| Hidetoshi Arima | |||
| Keiichi Motoyama | |||
| Taishi Higashi | |||
| Rena Nishiyama | |||
| Yuki Maeda | |||
| Yumi Hirai | |||
| P2860 | cites work | Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development | Q73850461 |
| Design, synthesis and evaluation of monovalent ligands for the asialoglycoprotein receptor (ASGP-R) | Q84569674 | ||
| Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression | Q21142752 | ||
| Niemann-Pick disease type C | Q21202883 | ||
| Identification of HE1 as the second gene of Niemann-Pick C disease | Q24290663 | ||
| Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis | Q24315133 | ||
| Autophagy in lysosomal storage disorders | Q24601671 | ||
| The role of autophagy in neurodegenerative disease | Q29614834 | ||
| Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control | Q31716904 | ||
| Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells | Q33777920 | ||
| Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin | Q33945068 | ||
| Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann-Pick C1-deficient cells | Q33947729 | ||
| Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse | Q34930699 | ||
| Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease | Q35205918 | ||
| β-Cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann-Pick type C disease. | Q35351552 | ||
| Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease | Q36714243 | ||
| 2-Hydroxypropyl-β-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy | Q37683328 | ||
| Niemann‐Pick type C disease: molecular mechanisms and potential therapeutic approaches | Q37784257 | ||
| Treatment options for lysosomal storage disorders: developing insights | Q38046227 | ||
| Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease | Q38315736 | ||
| Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications | Q38363250 | ||
| Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo | Q39068359 | ||
| HPGCD outperforms HPBCD as a potential treatment for Niemann-Pick disease type C during disease modeling with iPS cells. | Q39072413 | ||
| Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo | Q39185713 | ||
| Cyclodextrins in drug carrier systems | Q39754307 | ||
| Effects of cyclodextrin in two patients with Niemann-Pick Type C disease | Q40265254 | ||
| Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1 | Q41959895 | ||
| Alteration of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatous rabbit aorta | Q43619786 | ||
| Association of autophagy with cholesterol-accumulated compartments in Niemann-Pick disease type C cells | Q46063599 | ||
| P304 | page(s) | 2079-2086 | |
| P577 | publication date | 2015-11-03 | |
| P1433 | published in | Beilstein Journal of Organic Chemistry | Q2894008 |
| P1476 | title | Cholesterol lowering effects of mono-lactose-appended β-cyclodextrin in Niemann-Pick type C disease-like HepG2 cells | |
| P478 | volume | 11 |
| Q51737749 | In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-Pick Type C disease. |
| Q92305542 | In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease |
| Q42154145 | Superstructures with cyclodextrins: chemistry and applications III. |
| Q37587827 | Synthesis of multi-lactose-appended β-cyclodextrin and its cholesterol-lowering effects in Niemann-Pick type C disease-like HepG2 cells |
Search more.